WallStreetZenWallStreetZen

NASDAQ: PMVP
Pmv Pharmaceuticals Inc Stock Ownership - Who owns Pmv Pharmaceuticals?

Insider buying vs selling

Have Pmv Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Orbimed Advisors LLC10% Owner2023-11-2287,786$2.23
$195.76kSell
David Henry MacKPresident and CEO2023-10-18198,407$0.53
$105.16kBuy
Leila AllandChief Medical Officer2023-09-156,291$6.62
$41.65kSell
Deepika JalotaChief Development Officer2023-09-154,104$6.62
$27.17kSell
David Henry MacKPresident and CEO2023-08-0785,500$0.53
$45.32kBuy

1 of 1

PMVP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PMVP insiders and whales buy or sell their stock.

PMVP Shareholders

What type of owners hold Pmv Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC12.81%6,589,330$10.94MInsider
Orbimed Advisors LLC12.59%6,475,291$10.75MInstitution
Arnold L. Oronsky12.58%6,469,911$10.74MInsider
Interwest Partners X LP8.75%4,502,480$7.47MInsider
Jpmorgan Chase Co7.64%3,930,340$6.52MInstitution
Blackrock Inc6.28%3,229,797$5.36MInstitution
Arrowmark Colorado Holdings LLC5.28%2,714,143$4.51MInstitution
Euclidean Capital LLC5.11%2,627,643$4.36MInstitution
V. Oncology Scs Sicavsif Nextech4.91%2,528,290$4.20MInsider
Vanguard Group Inc4.68%2,405,307$3.99MInstitution

1 of 3

PMVP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PMVP62.78%37.22%Net Buying
MURA78.93%2.66%
CUE32.98%10.04%Net Buying
VAXX4.14%95.86%Net Buying
ALVR14.62%85.38%Net BuyingNet Selling

Pmv Pharmaceuticals Stock Ownership FAQ

Who owns Pmv Pharmaceuticals?

Pmv Pharmaceuticals (NASDAQ: PMVP) is owned by 90.32% institutional shareholders, 53.55% Pmv Pharmaceuticals insiders, and 0.00% retail investors. Orbimed Advisors LLC is the largest individual Pmv Pharmaceuticals shareholder, owning 6.59M shares representing 12.81% of the company. Orbimed Advisors LLC's Pmv Pharmaceuticals shares are currently valued at $10.87M.

If you're new to stock investing, here's how to buy Pmv Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.